Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Steamed ginger extract (GGE03; Zinoact) is a standardized botanical extract derived from *Zingiber officinale* (ginger) through a specialized high-temperature, high-pressure steam processing method. This process enriches the extract with 1-dehydro-6-gingerdione (GD), a thermally stable bioactive compound that is rare in raw ginger. Developed by Genencell in collaboration with 3H LABS Research Institute, GGE03 acts as a metabolic and inflammatory regulator by inhibiting the NF-κB signaling pathway and activating AMP-activated protein kinase (AMPK). It has been evaluated in clinical trials for its efficacy in reducing body weight and fat in overweight and obese individuals, as well as for treating functional dyspepsia and *Helicobacter pylori*-induced gastric conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on steamed ginger extract.